Atlas Trials

Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia

Clinical trial NCT03207724 · COMPLETED

Trial details

NCT number
NCT03207724
Sponsor
Andrew Hendifar, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic CancerCachexiaWeight Loss
Start date
2017-10-16
Primary completion
2019-11-21
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.